Lung cancer and pulmonology are inseparable e as lung cancer patients are invariably first seen by pulmonologists, often undergo diagnostic and staging procedures performed by pulmonologists, get evaluated by pulmonologists for fitness for surgical resection (in early stage disease), are treated by pulmonologists at certain geographical regions of the world, undergo follow up with pulmonologists for treatment related complications and/or symptom palliation related to either the disease or associated pulmonary co-morbid conditions. The current focus of this abstract is the role of diagnostic and therapeutic interventional pulmonology (IP) in the context of lung cancer. The growing armamentarium of IP includes several procedures as listed in Table 1 . Endobronchial biopsy (EBBx): This is the most frequently performed bronchoscopic procedure for diagnosis of lung cancer. Its relatively safe with a high diagnostic yield (76%-97%). As airway bleeding is one of the commonly encountered problems, the learning points include: 1)Hot (electrocautery enabled) biopsy from vascular lesions 2)Avoid biopsy from cavity 3)Avoid biopsy from an excavating ulcer with vascular supply 4)Avoid biopsy from tracheal tumor or tumor at the tracheal carina Importantly, biopsy with electrocautery enabled forceps does not affect the tissue quality or the diagnostic yield. Transbronchial lung biopsy (TBLB): In certain situations TBLB is needed for diagnosing diffuse infiltrative lung disease in the setting of lung cancer including but not limited to lymphangitis, drug-induced interstitial lung disease, radiation pneumonitis and secondary infection. As pneumothorax, airway bleeding and crush artefacts are the commonly encountered problems, the important learning point is: 1)Do not use cup forceps for doing TBLB. Alligator forceps is preferred. It is likely that the cup forceps cuts through the blood vessels, whereas the alligator forceps crushes the blood vessels, thus leading to higher bleeding with the former method. In addition, the cup forceps has a smaller diameter (4 mm) compared with the alligator forceps (7 mm) in the open position; thus, it possibly reaches the lung segments more distally compared with the alligator forceps, leading to more pneumothoraces. Bronchoscopic staging procedures: EBUS-TBNA is an accurate, safe and cost-effective tool for lung cancer staging. It has been shown to have a pooled sensitivity and specificity of 93% and 100% respectively. The subgroup of patients who were selected on the basis of CT or PET positive results had higher pooled sensitivity than those without any selection (94% vs. 76%; p<0.05). EBUS-TBNA and EUS-FNA have been shown to have similar yield but lower complication rates as compared to mediastinoscopy in the initial mediastinal staging of non-small cell lung cancer. These endosonographic procedures are also safe and highly specific (99%) for mediastinal restaging of lung cancer The important learning points are: 1) Use of EBUS-TBNA results in significantly shorter time to treatment decision compared to conventional techniques 2) Do not use conventional TBNA for staging of lung cancer. EBUS-TBNA is preferred for both diagnosis and staging 3) Upfront mediastinoscopy for lung cancer staging in untreated patients and for restaging in patients after neoadjuvant chemotherapy (or neoadjuvant chemoradiation) is not needed as endoscopic procedures (EBUS-TBNA, EUS-FNA or their combination) are preferred for both of these Medical thoracoscopy: Medical thoracoscopy is a very useful procedure for both diagnosis of malignant pleural effusions as well as performing pleurodesis. Most patients present late at our center with extensive pleural adhesions and fibrosis. In such cases, flexi-rigid thoracoscopy has a lower yield in such cases (73% vs. 98%). The important learning point is: 1) Do not use flexirigid thoracoscopy for diagnosis of malignant pleural effusions Rigid bronchoscopic procedures: These are often undertaken as part of intervention for airway obstruction/stenosis. The important learning points are: 1) Avoid complex intervention procedures using flexible bronchoscope -prefer doing them using a rigid bronchoscope 2) Avoid placing stents when the distal airways are involved 3) When in doubt, place a silicon stent. Silicon stents are easy to extract, work even in malignant disorders, can always be replaced by metallic stents. Sometimes, what appears malignant may not be so and in tuberculosis endemic countries, endobronchial tuberculosis is a great mimicker of malignancy 4) Never place uncovered metallic stent for malignant disorders 5) Do not place metallic Y-stents using flexible bronchoscopy as this can be associated with criss-crossing of guidewires, loss of airway control (and immediate conversion to rigid bronchoscopy) and need for fluoroscopic guidance 6) Do not place silicone stents using flexible bronchoscopy In summary, each bronchoscopic procedure has inherent risks and potential for unintended complications. Therefore, each procedure teaches us something. The crux of safety in the context of diagnostic and therapeutic IP in lung cancer is to avoid performing biopsy during flexible bronchoscopy in tracheal tumors associated with airway obstruction, to use EBUS-TBNA for diagnosing/staging lung cancer, performing all complex interventions with a rigid bronchoscope and avoiding stent placements in patients with distal airway involvement. The most important principle for IP and practice of medicine, in general, is Primum non nocere (first do no harm 
